Sionna Therapeutics, Inc. (SION) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Sionna Therapeutics, Inc. in 2026. The next earnings report is expected on November 11, 2026.
Next earnings date
11 Nov 2026
In 83 days
EPS estimate
-0.64
Revenue estimate
0
Past earnings
Latest earnings analysis
Sionna Therapeutics missed consensus estimates in its latest earnings report, with EPS of -$0.66 versus an estimate of -$0.65, while revenue was $0 and met expectations. In the prior quarter, EPS also fell short of expectations and revenue likewise met estimates.
No dividend history available.
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
Sionna Therapeutics, Inc. (SION) is scheduled to report earnings on November 11, 2026.
Sionna Therapeutics, Inc. (SION) last reported earnings on August 6, 2026.
Sionna Therapeutics, Inc. (SION) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.